0001562180-19-003789.txt : 20190702 0001562180-19-003789.hdr.sgml : 20190702 20190702171503 ACCESSION NUMBER: 0001562180-19-003789 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190628 FILED AS OF DATE: 20190702 DATE AS OF CHANGE: 20190702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RECUPERO ANTHONY J CENTRAL INDEX KEY: 0001210230 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38701 FILM NUMBER: 19938853 MAIL ADDRESS: STREET 1: C/O SI-BONE, INC. STREET 2: 471 EL CAMINO REAL, SUITE 101 CITY: SANTA CLARA STATE: CA ZIP: 95050 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SI-BONE, Inc. CENTRAL INDEX KEY: 0001459839 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 262216351 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 471 EL CAMINO REAL, SUITE 101 CITY: SANTA CLARA STATE: CA ZIP: 95050 BUSINESS PHONE: 4082070700 MAIL ADDRESS: STREET 1: 471 EL CAMINO REAL, SUITE 101 CITY: SANTA CLARA STATE: CA ZIP: 95050 FORMER COMPANY: FORMER CONFORMED NAME: SI-Bone Inc. DATE OF NAME CHANGE: 20090326 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-06-28 false 0001459839 SI-BONE, Inc. SIBN 0001210230 RECUPERO ANTHONY J C/O SI-BONE, INC. 471 EL CAMINO REAL, SUITE 101 SANTA CLARA CA 95050 false true false false Chief Commercial Officer Common Stock 2019-06-28 4 M false 900.00 4.32 A 20173.00 D Common Stock 2019-06-28 4 S false 900.00 20.00 D 19273.00 D Common Stock 2019-07-01 4 M false 1500.00 4.32 A 20773.00 D Common Stock 2019-07-01 4 S false 1500.00 20.1239 D 19273.00 D Stock Option (Right to Buy) 4.32 2019-06-28 4 M false 900.00 0.00 D 2026-07-26 Common Stock 900.00 121090.00 D Stock Option (Right to Buy) 4.32 2019-07-01 4 M false 1500.00 0.00 D 2026-07-26 Common Stock 1500.00 119590.00 D Includes 18,469 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.84 to $20.56, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The shares subject to the option vest as to 25% on the 12-month anniversary of vesting commencement date, and 1/36th of the balance of the shares vest each month thereafter, subject to Reporting Person's continued service through each relevant vesting date. /s/ Michael A. Pisetsky, Attorney-in-Fact for Anthony J. Recupero 2019-07-02